Therefore, heterologous expression of the “DNA repair protein RAD51homolog 1” (target si42, identified in our present study) via strategies based onthe concept of `DNA vaccines’ might eventually be useful for people submitted toradiotherapy during treatment against cancer. The gene discussed is XRCC6P5; the disease is cancer.